These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4136699)

  • 1. Effects of cyclophosphamide on B- and T-lymphocytes in rheumatoid arthritis.
    Clements PJ; Yu DT; Levy J; Paulus HE; Barnett EV
    Arthritis Rheum; 1974; 17(4):347-53. PubMed ID: 4136699
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective depletion of Ig-bearing lymphocytes by cyclophosphamide in rheumatoid arthritis and systemic lupus erythematosus. Guidelines for dosage.
    Horwitz DA
    Arthritis Rheum; 1974; 17(4):363-74. PubMed ID: 4605097
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseases.
    Hurd ER; Giuliano VJ
    Arthritis Rheum; 1975; 18(1):67-75. PubMed ID: 1078778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on synovial fluid lymphocytes in rheumatoid arthritis.
    Sheldon PJ; Papamichail M; Holborow EJ
    Ann Rheum Dis; 1974 Nov; 33(6):509-14. PubMed ID: 4548344
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte characteristics in rheumatic patients and the effect of azathioprine therapy.
    Yy DT; Clements PJ; Peter JB; Levy J; Paulus HE; Barnett EV
    Arthritis Rheum; 1974; 17(1):37-45. PubMed ID: 4589815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic background of chronic rheumatoid arthritis--its past, present and future].
    Kyogoku K
    Ryumachi; 1974 Jul; 14(2):155-60. PubMed ID: 4616375
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic effects of cyclophosphamide treatment in rheumatoid arthritis.
    Alepa FP; Zvaifler NJ; Sliwinski AJ
    Arthritis Rheum; 1970; 13(6):754-60. PubMed ID: 5495387
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characteristics of the cellular and humoral immune response in rheumatoid polyarthritis].
    Duţu A; Popescu MR; Rusu ML; Părău N; Urcan S; Radu D; Coldea A; Dejica D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(5):461-7. PubMed ID: 6134323
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of clinico-immunological indices for the evaluation of the efficacy of the basic therapy of rheumatoid arthritis].
    Tsitlanadze VG; Dzidziguri LM; Tkemaladze LM; Kartvelishvili EIu; Shakulashvili NA
    Ter Arkh; 1981; 53(7):72-4. PubMed ID: 6974910
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation of cellular infiltration of rheumatoid synovial membrane to its immune response.
    Ziff M
    Arthritis Rheum; 1974; 17(3):313-9. PubMed ID: 4545206
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of androgens in rheumatic diseases.
    Cutolo M; Seriolo B; Pizzorni C; Sulli A
    Isr Med Assoc J; 2001 Oct; 3(10):743-8. PubMed ID: 11692549
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cellular immunity in rheumatoid arthritis. Effect of therapy].
    Roux H; Mercier P; Jeandel P; Brouillet-Gabriel M; Serratrice G
    Rev Rhum Mal Osteoartic; 1977 May; 44(5):331-4. PubMed ID: 329399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

  • 14. B- and T-lymphocytes in rheumatoid synovitis and the effect of cyclophosphamide.
    Ziff M; Hurd ER; Stastny P
    Proc R Soc Med; 1974 Jun; 67(6 Pt 2):536-40. PubMed ID: 4604142
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular aspects of tolerance. IV. Strain variations of tolerance induceability.
    Fujiwara M; Cinader B
    Cell Immunol; 1974 Apr; 12(1):11-29. PubMed ID: 4142413
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological disorders in seronegative and seropositive rheumatoid arthritis].
    Benenson EV; Seĭsenbaev ASh
    Ter Arkh; 1983; 55(7):42-6. PubMed ID: 6604959
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for altered immunoregulation in rheumatoid arthritis.
    Dobloug JH; Førre O; Chattopadhyay C; Natvig JB
    Springer Semin Immunopathol; 1981; 4(2):125-31. PubMed ID: 6976647
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)].
    Di Matteo L; D'Incecco V; Evangelista L; Castiglione C; Consoli G
    Boll Soc Ital Biol Sper; 1985 May; 61(5):777-81. PubMed ID: 3927943
    [No Abstract]   [Full Text] [Related]  

  • 19. Thymosin-induced reduction of "null cells" in peripheral-blood lymphocytes of patients with systemic lupus erythematosus.
    Scheinberg MA; Cathcart ES; Goldstein AL
    Lancet; 1975 Feb; 1(7904):424-6. PubMed ID: 48612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity in rheumatoid arthritis.
    Jiménez López A; Olmos Martínez JM
    Allergol Immunopathol (Madr); 1982; 10(6):471-9. PubMed ID: 6762823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.